Liver, pancreas transplant programs suspended at UF’s Shands HealthCare
Shands HealthCare at the University of Florida has suspended its liver and pancreas transplant programs after the sudden departure of three of its four organ transplant surgeons. The Gainesville transplant center took the action Friday and over the weekend tried to notify all 125 patients waiting for new organs. "If you have a busy transplant program, and you lose even a couple surgeons, it's a major blow," said Kevin Behrns, MD, chairman of surgery at UF's College of Medicine. He is working to recruit multi-organ surgeons who are trained to transplant livers, pancreases and kidneys. Patients waiting for a new liver or pancreas will be placed on another hospital list until Shands can reopen its program, he said. The move should not delay their treatment. The United Network for Organ Sharing is working with Shands to connect patients to other transplant centers. The nearest ones are the Mayo Clinic in Jacksonville, Florida Hospital in Orlando and Tampa General Hospital.
- Providers Lag as Consumers Set Agenda
- Look Beyond Nurse-Patient Ratios
- Esther Dyson Launches Population Health Challenge
- Crisis Spurs Healthcare Payment Reform in Arkansas
- ICD-10 Delay Alters Provider, Vendor Prep
- Reform Puts Vise Grips on Physicians
- Hospital Groups Back NQF Report on Patient Sociodemographics
- Payment Reform Naysayers 'Better Wake Up'
- NPP Demand Rising Under Value-Based Care Models
- Reduce Readmissions by Activating Patients to Do 'Self-Care'